MISSION CREEK CAPITAL PARTNERS, INC. – Gilead Sciences, Inc. Transaction History
MISSION CREEK CAPITAL PARTNERS, INC. portfolio value:
$955,000
portfolio value
MISSION CREEK CAPITAL PARTNERS, INC. quarter portfolio value change:
-0.19%
quarter
Gilead Sciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -1.12% | -175 shares | -13K | $61.69 | 15.48K |
| Q2 2022 | share | Decrease | -0.32% | -50 shares | 34K | $61.81 | 15.65K |
| Q1 2022 | share | Decrease | -5.99% | -1.00K shares | -279K | $59.45 | 15.70K |
| Q4 2021 | share | Decrease | -8.57% | -1.56K shares | -63K | $73.36 | 16.70K |
| Q3 2021 | share | Decrease | -2.51% | -470 shares | -15K | $69.85 | 18.27K |
| Q2 2021 | share | Decrease | -3.52% | -683 shares | 35K | $68.17 | 18.74K |
| Q1 2021 | share | Decrease | -1.34% | -263 shares | 109K | $63.33 | 19.42K |
| Q4 2020 | share | Decrease | -0.52% | -102 shares | -104K | $56.43 | 19.68K |
| Q3 2020 | share | Increase | +149.48% | 11.85K shares | 641K | $60.52 | 19.79K |
| Q2 2020 | share | Decrease | -0.31% | -25 shares | 15K | $72.94 | 7.93K |
| Q1 2020 | share | Decrease | -0.87% | -70 shares | 73K | $70.22 | 7.95K |
| Q4 2019 | share | Increase | 0.00% | 8.02K shares | 522K | $60.43 | 8.02K |